Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Invest in the Future of Cancer Immunotherapy & Women’s Health
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Invest in the Future of Cancer Immunotherapy & Women’s Health
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
01/29/02 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-10.14
EX-10.15
EX-23.1
HTML PDF 48
02/01/01 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
HTML PDF 35
01/29/01 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
HTML PDF 35
01/28/00 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-21
EX-23.1
EX-27
EX-99.1
HTML PDF 60
03/31/99 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF 13
01/29/99 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 42
01/29/98 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 40
01/29/97 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-23.1
EX-27
EX-99.1
HTML PDF 35
01/29/96 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-10.31
EX-23.1
EX-27
HTML PDF 44
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...
Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...
Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...
Copyrights © 2025 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Terms of Use Disclaimer Sitemap